Condition: Fear of Cancer Recurrence, Renal Cell Carcinoma (Kidney Cancer)

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT07234656

Sponsor: Brigitta Rasmussen Villumsen

Phase:

Eligibility:

• Age: minimum N/A maximum N/A
• Gender: All

Inclusion Criteria:

• Phase 1:
• Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse
• Partner/spouse to patients who fullfil the inclusion criteria
• Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)
• Time since surgery: 0-120 months
• Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish
• Patients/partners/spouses able to and willing to attend online project meetings or in person at Gødstrup Hospital. Phase 2:
• Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse
• Partner/spouse to patients who fullfill the inclusion criteria
• Patients who have undergone surgery due to localized RCC (T1-T2-T3 tumor)
• Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish
• Able to receive digital communication from the hospital
• Informed consent must be signed before answering Fear of Cancer Recurrence questions

Exclusion Criteria:

• Both phases, both patients and partners/spouses:
• Diagnosed with cognitive impairment
• Untreated psychiatric disorders due to non-compliance Phase 2: • Patients and partners/spouses who were panelists in phase 1

View trial on ClinicalTrials.gov